A SIMPLE KEY FOR HEMGENIX UNVEILED

Quantity of suitable people: CDEC discussed the uncertainty in the number of individuals with moderately severe to extreme hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some individuals who're classified as possessing moderate or reasonable disease could have a significant bl